Table 3.
PRS association with clinical variables of risperidone treatment response
| Clinical variables (follow-up - baseline) | N | B | p-value | |
|---|---|---|---|---|
| Five-factor model21 | ΔPANSS negative | 53 | −71.6 | 0.5948 |
| ΔPANSS positive | 53 | −74.5 | 0.6824 | |
| ΔPANSS disorganization | 53 | −35.3 | 0.8493 | |
| ΔPANSS depression/anxiety | 52 | 222.7 | 0.1173 | |
| aΔPANSS excitement | 53 | 473.5 | 0.0034 | |
| bΔCDSS | 49 | 717.2 | 0.0006 | |
Delta was calculated subtracting the measures of follow-up minus the baseline
aSignificant p-values without Bonferroni correction
bSignificant p-values with Bonferroni correction